首页|不同种类益生菌联合丙种球蛋白治疗新生儿ABO溶血性黄疸的临床效果研究

不同种类益生菌联合丙种球蛋白治疗新生儿ABO溶血性黄疸的临床效果研究

扫码查看
目的 探讨不同种类益生菌联合丙种球蛋白治疗新生儿ABO溶血性黄疸的临床效果。方法 选取 2022 年 9 月至 2023 年 10 月赣州市人民医院诊断为新生儿ABO溶血性黄疸的 160 例患儿为研究对象,采用随机数字表法,将研究对象随机分入四组(空白组、A组、B组、C组),每组各 40 例。四组患儿均采用丙种球蛋白输注、蓝光照射治疗,A组加用双歧杆菌三联菌,B组患儿加用枯草杆菌二联活菌颗粒,C组加用布拉氏酵母菌散治疗。分析比较四组临床疗效,血清胆红素(TBIL)水平,体质量增加情况,退黄时间,治疗期间平均每日摄奶量及黄疸退而复现发生率。结果 治疗前,四组TBIL水平相比,差异无统计学意义(P>0。05);治疗后,四组TBIL水平均降低,A、B、C组低于空白组,其中A组降低幅度更大,差异有统计学意义(P<0。05);B组与C组两组TBIL水平相比,差异无统计学意义(P>0。05)。A、B、C组体质量增长高于空白组,退黄时间短于空白组,治疗期间平均每日摄奶量多于空白组,差异有统计学意义(P<0。05),但A、B、C组对比差异无统计学意义(P>0。05)。四组黄疸退而复现发生率对比差异无统计学意义(P<0。05)。结论 三种益生菌联合丙种球蛋白治疗新生儿ABO溶血性黄疸,均能有效改善患儿黄疸症状,有效降低胆红素水平,提高治疗效果,促进患儿生长发育,但双歧杆菌三联活菌降低胆红素水平更明显。
Clinical Efficacy of Different Types of Probiotics Combined with Gamma Globulin in the Treatment of Neonatal ABO Hemolytic Jaundice
Objective To explore the clinical efficacy of different types of probiotics combined with gamma globulin in the treatment of neonatal ABO hemolytic jaundice.Methods 160 children diagnosed with neonatal ABO hemolytic jaundice admitted to the Ganzhou People's Hospital from September 2022 to October 2023 were selected as the study subjects.Using a random number table method,the study subjects were randomly divided into four groups:blank,A,B,and C group,with 40 cases in each group.The four groups were all treated with gamma globulin infusion and blue light irradiation.Group A was added with bifidobacterium triple bacteria,group B was added with live bacillus subtilis and enterococcus faeciu,and group C was added with saccharomyces boulardii.Analyze and compare the clinical efficacy,serum bilirubin(TBIL)levels,weight gain,time to jaundice regression,average daily milk intake during treatment,and recurrence rate of jaundice regression between two groups.Results Before treatment,there was no significant difference in TBIL levels among the four groups(P>0.05);after treatment,the TBIL levels in all four groups decreased,with A,B,and C groups being lower than the blank group,with A group showing a greater decrease(P<0.05);the difference in TBIL levels between group B and group C was not significant(P>0.05).The weight gain of group A,B and C was higher than that of the blank group,and the jaundice regression time was shorter than that of the blank group.During the treatment period,the average daily milk intake was higher than that of the blank group(P<0.05),but the difference between groups A,B,and C was not significant(P>0.05);there was no significant difference in the incidence of jaundice recurrence among the four groups(P<0.05).Conclusion The combination of three probiotics and gamma globulin in the treatment of neonatal ABO hemolytic jaundice can effectively improve the symptoms of jaundice,reduce bilirubin levels,improve treatment effectiveness,and promote the growth and development of the child.However,the reduction of bilirubin levels by bifidobacterium triple bacteria is more significant.

Neonatal ABO hemolytic jaundiceGamma globulinLive bacillus subtilis and rnterococcus faeciuBifidobacterium triple bacteriaSaccharomyces boulardii

熊璐、刘志雄、夏俊超、张玉玲、董显燕

展开 >

赣州市人民医院,江西 赣州 341000

新生儿ABO溶血性黄疸 丙种球蛋白 枯草杆菌二联活菌 双歧杆菌三联菌 布拉氏酵母菌

2024

药品评价
江西省药学会

药品评价

影响因子:0.672
ISSN:1672-2809
年,卷(期):2024.21(3)